Oncternal Therapeutics Inc. sell Lokrim
Start price
31.05.22
/
20%
€1.39
Target price
31.05.23
-
Performance (%)
-82.87%
End price
24.04.23
€0.24
Summary
This prediction ended on 24.04.23 with a price of €0.24. Lokrim correctly predicted massive losses of -82.87% for Oncternal Therapeutics Inc.. Lokrim has 20% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Oncternal Therapeutics Inc. | - | - | - |
iShares Core DAX® | 1.518% | 3.456% | 25.970% |
iShares Nasdaq 100 | 1.240% | 2.983% | 31.325% |
iShares Nikkei 225® | 2.808% | 2.743% | 19.597% |
iShares S&P 500 | 0.403% | 2.187% | 28.624% |
According to Lokrim what are the pros and cons of Oncternal Therapeutics Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by Lokrim for this prediction
In the thread Oncternal Therapeutics Inc. diskutieren
Sell Oncternal Therapeutics Inc.
In the thread Trading Oncternal Therapeutics Inc.
Sell beendet